Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Healthtrust
UBS
Federal Trade Commission
QuintilesIMS
Teva
Merck
Medtronic
US Army

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,855,230

« Back to Dashboard

Which drugs does patent 7,855,230 protect, and when does it expire?

Patent 7,855,230 protects TOVIAZ and is included in one NDA.

This patent has fifty-one patent family members in twenty-eight countries.
Summary for Patent: 7,855,230
Title:Derivatives of 3,3-diphenylpropylamines
Abstract:The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the invention relates to novel prodrugs of antimuscarinic agents with superior pharmacokinetic properties compared to existing drugs such as oxybutynin and tolterodine, methods for their preparation, pharmaceutical compositions containing them, a method of using said compounds and compositions for the treatment of urinary incontinence, gastrointestinal hyperactivity (irritable bowel syndrome) and other smooth muscle contractile conditions.
Inventor(s): Meese; Claus (Monheim, DE), Sparf; Bengt (Transgund, SE)
Assignee: UCB Pharma GmbH (Monheim, DE)
Application Number:12/105,016
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,855,230
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 7,855,230

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pfizer TOVIAZ fesoterodine fumarate TABLET, EXTENDED RELEASE;ORAL 022030-001 Oct 31, 2008 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY, AND FREQUENCY ➤ Try a Free Trial
Pfizer TOVIAZ fesoterodine fumarate TABLET, EXTENDED RELEASE;ORAL 022030-002 Oct 31, 2008 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY, AND FREQUENCY ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,855,230

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,384,980 Derivatives of 3,3-diphenylpropylamines ➤ Try a Free Trial
6,713,464 Derivatives of 3,3-diphenylpropylamines ➤ Try a Free Trial
8,338,478 Derivatives of 3,3-diphenylpropylamines ➤ Try a Free Trial
7,985,772 Derivatives of 3,3-diphenylpropylamines ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 7,855,230

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1690041 ➤ Try a Free Trial
China 100491336 ➤ Try a Free Trial
Czech Republic 20003774 ➤ Try a Free Trial
Czech Republic 296605 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
US Army
Chinese Patent Office
Express Scripts
Farmers Insurance
McKesson
QuintilesIMS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.